Project Grant HT94252410138
Award Date 4/1/24
Completion Date 3/31/28
Dollars Obligated $2.6M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60637, USA
Similar Awards
- The University of Chicago will receive $2,624,000 through a Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to investigate the role of amino acid metabolism in pulmonary fibrosis. Through this award, the University of Chicago aims to advance understanding of medical solutions for pulmonary disorders and translate findings into improved patient...
- The University of Chicago was awarded a $1,306,778 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "IMMUNOLOGIC DRIVERS OF LINEAGE BIAS IN TP53-MUTANT ACUTE LEUKEMIA". This 4-year grant, beginning on August 1, 2025, will support the university's advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research project...
- The University of Chicago was awarded a $869,193 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on July 1, 2025. The grant supports research to identify the pathogenesis of monosomy 7 in bone marrow failure, with an expected completion date of June 30, 2028. The University of Chicago is a leading academic institution with extensive expertise in conducting advanced biomedical research to address critical medical challenges...
- This federal Project Grant award of $820,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) was provided to the University of Chicago to conduct research on "Determining and Exploiting Metabolic Vulnerabilities of Cancer-Associated Fibroblast Heterogeneity." The research project aims to explore metabolic differences within cancer-associated fibroblasts and leverage those findings to develop new therapeutic approaches. The...
- The University of Chicago has been awarded a $426,400.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from September 1, 2025 to August 31, 2027, supports the university's research on "Nanoscale Structural and Molecular Mapping of the Optic Nervous System Following Ocular Blast." This advanced biomedical research aims to transform healthcare for military service members, veterans, and the...
- The University of Chicago will receive $1,229,184 from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) from July 1, 2022 to June 30, 2025. The funding will support research into microRNA-mediated regulation of prostate cancer biology. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions for battlefield medicine. The University of...
- The University of Chicago was awarded a $574,000 Project Grant from the Defense Health Agency to support a research project titled "A HUMAN PLURIPOTENT STEM CELL-BASED APPROACH TO IDENTIFYING THE DRIVERS OF PULMONARY CARCINOID". The grant is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on transforming health care for service members and the public through innovative biomedical research. The project, spanning from September 1, 2023 to...
- This federal Project Grant award from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), provides $3,085,852.00 to the University of Chicago to develop novel claudin-2 channel blockers for the treatment of inflammatory bowel disease. The 4-year project, starting on Jul 1, 2024 and ending on Jun 30, 2028, aims to advance the research and development of new therapeutic approaches for this debilitating condition. As a leading...
- This federal Project Grant award of $1,612,104.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the University of Chicago to develop senescent tumor cell-loaded dendritic cell vaccines for breast cancer. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative medical solutions to critical health challenges. The 3-year...
- The University of Michigan was awarded a $448,133 project grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Targeting Mycobiome Metabolism to Reprogram the Immunosuppressive Pancreatic Tumor Microenvironment". This 3-year research project, beginning on November 1, 2025, seeks to investigate innovative approaches to transform healthcare for military service members, veterans, and the broader...